Form 4 for ELAN Elanco Animal Health Inc
Accepted 2026-05-26 16:43:19 ET · period of report 2026-05-21 · accession 0001872431-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-26 16:43 | 2026-05-21 | ELAN | Ma Stacey | Dir | A - Grant | $0.00 | +16.9K | 29.7K | +131% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | A | A | 4,678 | $0.00 | 17,531 | D | — | — | (F1) Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
| 2 | Common | Common Stock | 2026-05-21 | A | A | 12,196 | $0.00 | 29,727 | D | — | — | (F2) Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. |